Literature DB >> 17557817

ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity.

Marien I de Jonge1, Gérard Pehau-Arnaudet, Marjan M Fretz, Felix Romain, Daria Bottai, Priscille Brodin, Nadine Honoré, Gilles Marchal, Wim Jiskoot, Patrick England, Stewart T Cole, Roland Brosch.   

Abstract

The 6-kDa early secreted antigenic target ESAT-6 and the 10-kDa culture filtrate protein CFP-10 of Mycobacterium tuberculosis are secreted by the ESX-1 system into the host cell and thereby contribute to pathogenicity. Although different studies performed at the organismal and cellular levels have helped to explain ESX-1-associated phenomena, not much is known about how ESAT-6 and CFP-10 contribute to pathogenesis at the molecular level. In this study we describe the interaction of both proteins with lipid bilayers, using biologically relevant liposomal preparations containing dimyristoylphosphatidylcholine (DMPC), dimyristoylphosphatidylglycerol, and cholesterol. Using flotation gradient centrifugation, we demonstrate that ESAT-6 showed strong association with liposomes, and in particular with preparations containing DMPC and cholesterol, whereas the interaction of CFP-10 with membranes appeared to be weaker and less specific. Most importantly, binding to the biomembranes no longer occurred when the proteins were present as a 1:1 ESAT-6.CFP-10 complex. However, lowering of the pH resulted in dissociation of the protein complex and subsequent protein-liposome interaction. Finally, cryoelectron microscopy revealed that ESAT-6 destabilized and lysed liposomes, whereas CFP-10 did not. In conclusion, we propose that one of the main features of ESAT-6 in the infection process of M. tuberculosis is the interaction with biomembranes that occurs after dissociation from its putative chaperone CFP-10 under acidic conditions typically encountered in the phagosome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17557817      PMCID: PMC1952024          DOI: 10.1128/JB.00469-07

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  52 in total

1.  ATP-mediated killing of Mycobacterium bovis bacille Calmette-Guérin within human macrophages is calcium dependent and associated with the acidification of mycobacteria-containing phagosomes.

Authors:  C B Stober; D A Lammas; C M Li; D S Kumararatne; S L Lightman; C A McArdle
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

2.  Essential role for cholesterol in entry of mycobacteria into macrophages.

Authors:  J Gatfield; J Pieters
Journal:  Science       Date:  2000-06-02       Impact factor: 47.728

3.  C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis.

Authors:  Patricia A Digiuseppe Champion; Sarah A Stanley; Matthew M Champion; Eric J Brown; Jeffery S Cox
Journal:  Science       Date:  2006-09-15       Impact factor: 47.728

4.  Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis.

Authors:  Michael Strong; Michael R Sawaya; Shuishu Wang; Martin Phillips; Duilio Cascio; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-11       Impact factor: 11.205

5.  M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells.

Authors:  Nicole van der Wel; David Hava; Diane Houben; Donna Fluitsma; Maaike van Zon; Jason Pierson; Michael Brenner; Peter J Peters
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

6.  Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages.

Authors:  Sushil Kumar Pathak; Sanchita Basu; Kunal Kumar Basu; Anirban Banerjee; Shresh Pathak; Asima Bhattacharyya; Tsuneyasu Kaisho; Manikuntala Kundu; Joyoti Basu
Journal:  Nat Immunol       Date:  2007-05-07       Impact factor: 25.606

7.  Structural analysis of the protein/lipid complexes associated with pore formation by the bacterial toxin pneumolysin.

Authors:  B B Bonev; R J Gilbert; P W Andrew; O Byron; A Watts
Journal:  J Biol Chem       Date:  2000-11-13       Impact factor: 5.157

8.  Mycobacteria lacking the RD1 region do not induce necrosis in the lungs of mice lacking interferon-gamma.

Authors:  Ana Paula Junqueira-Kipnis; Randall J Basaraba; Veronica Gruppo; Gopinath Palanisamy; Oliver C Turner; Tsungda Hsu; William R Jacobs; Scott A Fulton; Scott M Reba; W Henry Boom; Ian M Orme
Journal:  Immunology       Date:  2006-10       Impact factor: 7.397

9.  Analysis of the proteome of Mycobacterium tuberculosis in silico.

Authors:  F Tekaia; S V Gordon; T Garnier; R Brosch; B G Barrell; S T Cole
Journal:  Tuber Lung Dis       Date:  1999

10.  A specific secretion system mediates PPE41 transport in pathogenic mycobacteria.

Authors:  Abdallah M Abdallah; Theo Verboom; Fredericke Hannes; Mohamad Safi; Michael Strong; David Eisenberg; René J P Musters; Christina M J E Vandenbroucke-Grauls; Ben J Appelmelk; Joen Luirink; Wilbert Bitter
Journal:  Mol Microbiol       Date:  2006-11       Impact factor: 3.501

View more
  131 in total

1.  The crystal structure of the Mycobacterium tuberculosis Rv3019c-Rv3020c ESX complex reveals a domain-swapped heterotetramer.

Authors:  Mark A Arbing; Markus Kaufmann; Tung Phan; Sum Chan; Duilio Cascio; David Eisenberg
Journal:  Protein Sci       Date:  2010-09       Impact factor: 6.725

Review 2.  Protein export systems of Mycobacterium tuberculosis: novel targets for drug development?

Authors:  Meghan E Feltcher; Jonathan Tabb Sullivan; Miriam Braunstein
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

3.  Characterization of Mycobacterium tuberculosis EsxA membrane insertion: roles of N- and C-terminal flexible arms and central helix-turn-helix motif.

Authors:  Yue Ma; Verena Keil; Jianjun Sun
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

4.  Retention of EsxA in the Capsule-Like Layer of Mycobacterium tuberculosis Is Associated with Cytotoxicity and Is Counteracted by Lung Surfactant.

Authors:  Johanna Raffetseder; Nino Iakobachvili; Vesa Loitto; Peter J Peters; Maria Lerm
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

Review 5.  Type VII secretion systems: structure, functions and transport models.

Authors:  Angel Rivera-Calzada; Nikolaos Famelis; Oscar Llorca; Sebastian Geibel
Journal:  Nat Rev Microbiol       Date:  2021-05-26       Impact factor: 60.633

6.  Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium.

Authors:  Hannah E Volkman; Tamara C Pozos; John Zheng; J Muse Davis; John F Rawls; Lalita Ramakrishnan
Journal:  Science       Date:  2009-12-10       Impact factor: 47.728

Review 7.  ESX secretion systems: mycobacterial evolution to counter host immunity.

Authors:  Matthias I Gröschel; Fadel Sayes; Roxane Simeone; Laleh Majlessi; Roland Brosch
Journal:  Nat Rev Microbiol       Date:  2016-09-26       Impact factor: 60.633

8.  Potential role for ESAT6 in dissemination of M. tuberculosis via human lung epithelial cells.

Authors:  Arvind G Kinhikar; Indu Verma; Dinesh Chandra; Krishna K Singh; Karin Weldingh; Peter Andersen; Tsungda Hsu; William R Jacobs; Suman Laal
Journal:  Mol Microbiol       Date:  2009-11-10       Impact factor: 3.501

9.  Evidence for pore formation in host cell membranes by ESX-1-secreted ESAT-6 and its role in Mycobacterium marinum escape from the vacuole.

Authors:  Jennifer Smith; Joanna Manoranjan; Miao Pan; Amro Bohsali; Junjie Xu; Jun Liu; Kent L McDonald; Agnieszka Szyk; Nicole LaRonde-LeBlanc; Lian-Yong Gao
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

10.  Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses.

Authors:  Xisheng Wang; Peter F Barnes; Fangfang Huang; Ivana B Alvarez; Pierre F Neuenschwander; David R Sherman; Buka Samten
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.